Related references
Note: Only part of the references are listed.Metabolic-Associated Fatty Liver Disease and Sarcopenia
Triada Bali et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2023)
Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers
Zhenqiu Liu et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2022)
Identification of Preoperative Fat-Free Mass Index for the Prognosis of Curatively Resected Esophageal Cancer
Akikazu Yago et al.
WORLD JOURNAL OF SURGERY (2022)
Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota
Karolina Drozdz et al.
NUTRIENTS (2022)
Increased estimated fat-free mass and fat mass associated with improved clinical outcome in heart failure
Israel Gotsman et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2022)
MAFLD: Renovation of clinical practice and disease awareness of fatty liver
Takumi Kawaguchi et al.
HEPATOLOGY RESEARCH (2022)
Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China
Yebei Liang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Systematic Review: The Impact and Importance of Body Composition in Inflammatory Bowel Disease
Nik Sheng Ding et al.
JOURNAL OF CROHNS & COLITIS (2022)
Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis
Xinxing Tantai et al.
JOURNAL OF HEPATOLOGY (2022)
Sarcopenic Obesity in Children and Adolescents: A Systematic Review
Marcela Zembura et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
The prevalence of low muscle mass associated with obesity in the USA
Dana J. Murdock et al.
SKELETAL MUSCLE (2022)
MAFLD 2022: An ELPA/ALPA/EASO-ECPO joint statement on disease stigma
Gamal Shiha et al.
JOURNAL OF HEPATOLOGY (2022)
Fat-Free Mass Index as a Surrogate Marker of Appendicular Skeletal Muscle Mass Index for Low Muscle Mass Screening in Sarcopenia
Ryoko Kawakami et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2022)
Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review
Jenny Lee et al.
LIVER INTERNATIONAL (2021)
Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases
Jorge Gutierrez-Cuevas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review
Yoshihiro Kamada et al.
JOURNAL OF GASTROENTEROLOGY (2021)
An association between visceral or subcutaneous fat accumulation and diabetes mellitus among Japanese subjects
Hirohide Yokokawa et al.
DIABETOLOGY & METABOLIC SYNDROME (2021)
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
Katsutoshi Tokushige et al.
JOURNAL OF GASTROENTEROLOGY (2021)
Fat-Free Mass Index Controlled for Age and Sex and Malnutrition Are Predictors of Survival in Interstitial Lung Disease
Sylvia Rinaldi et al.
RESPIRATION (2021)
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
Liang-Kung Chen et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
Sakura Yamamura et al.
LIVER INTERNATIONAL (2020)
Epidemiology of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan: A focused literature review
Yuichiro Eguchi et al.
JGH OPEN (2020)
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
Eduardo Vilar-Gomez et al.
JOURNAL OF HEPATOLOGY (2018)
The criteria for metabolic syndrome and the national health screening and education system in Japan
Kazumasa Yamagishi et al.
EPIDEMIOLOGY AND HEALTH (2017)
Characteristics of non-obese non-alcoholic fatty liver disease: Effect of genetic and environmental factors
Yasushi Honda et al.
HEPATOLOGY RESEARCH (2016)
Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria
Hiroki Nishikawa et al.
HEPATOLOGY RESEARCH (2016)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
The impact of low preoperative fat-free body mass on infections and length of stay after cardiac surgery: A prospective cohort study
Lenny M. W. van Venrooij et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2011)